Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristics
- PMID: 1660295
- DOI: 10.1016/0277-5379(91)90030-h
Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristics
Abstract
The presence of progesterone, oestrogen, somatostatin and epidermal growth factor receptors of 24 meningiomas was related with their radiological CT appearance. Progesterone receptors were present in 16 of 21 (76%), oestrogen receptors in 4 of 21 (19%), somatostatin receptors on 23 of 24 (96%) and epidermal growth factor receptors on 17 of 19 (89%) meningiomas. There was no relationship between the presence of these receptors and the age or sex of the patients, tumour histology, tumour localisation, the presence of perifocal oedema, displacement of the midline cerebri or obstructive hydrocephalus on CT scan. There was a negative correlation (P less than 0.05) between the number of progesterone receptors and "malignant" behaviour of the meningiomas on CT (e.g. the presence of necrosis, cyst formation, intratumoral haemorrhage, irregular surface and/or inhomogeneous attenuation of contrast). The observation that aggressive tumour behaviour on CT is accompanied by low numbers or absence of progesterone receptors makes these meningiomas less attractive candidates for medical therapy with antiprogestins.
Similar articles
-
Meningiomas, epidermal growth factor and progesterone.Hum Reprod. 1994 Jun;9 Suppl 1:190-4. doi: 10.1093/humrep/9.suppl_1.190. Hum Reprod. 1994. PMID: 7962464
-
[Analysis of estradiol and progesterone receptors in meningioma].Neurochirurgia (Stuttg). 1986 Jul;29(4):99-104. doi: 10.1055/s-2008-1054147. Neurochirurgia (Stuttg). 1986. PMID: 3748266 German.
-
Oestrogen receptors in meningiomas: a correlative PET and immunohistochemical study.Nucl Med Commun. 1997 Jul;18(7):606-15. doi: 10.1097/00006231-199707000-00003. Nucl Med Commun. 1997. PMID: 9342097
-
Brain oedema in secretory meningiomas.J Clin Neurosci. 2001 May;8 Suppl 1:19-21. doi: 10.1054/jocn.2001.0871. J Clin Neurosci. 2001. PMID: 11386820 Review.
-
Endocrine aspects of the diagnosis and treatment of primary brain tumours.Clin Endocrinol (Oxf). 1992 Jul;37(1):1-10. doi: 10.1111/j.1365-2265.1992.tb02276.x. Clin Endocrinol (Oxf). 1992. PMID: 1330382 Review. No abstract available.
Cited by
-
Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.J Neurooncol. 2009 Mar;92(1):1-6. doi: 10.1007/s11060-008-9734-y. Epub 2008 Nov 21. J Neurooncol. 2009. PMID: 19023520 Review.
-
Molecular characteristics of meningiomas.J Pathol Transl Med. 2020 Jan;54(1):45-63. doi: 10.4132/jptm.2019.11.05. Epub 2020 Jan 15. J Pathol Transl Med. 2020. PMID: 31964111 Free PMC article. Review.
-
The future of antihormone therapy: innovations based on an established principle.J Cancer Res Clin Oncol. 1996;122(7):383-96. doi: 10.1007/BF01212877. J Cancer Res Clin Oncol. 1996. PMID: 8690748 Free PMC article. Review.
-
Expression and clinical value of EGFR in human meningiomas.PeerJ. 2017 Mar 29;5:e3140. doi: 10.7717/peerj.3140. eCollection 2017. PeerJ. 2017. PMID: 28367377 Free PMC article.
-
Minimally Invasive Approaches in the Surgical Treatment of Intracranial Meningiomas: An Analysis of 54 Cases.Brain Tumor Res Treat. 2024 Apr;12(2):93-99. doi: 10.14791/btrt.2024.0005. Brain Tumor Res Treat. 2024. PMID: 38742257 Free PMC article.